Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shire Regenerative Medicine Inc.

Division of Takeda Pharmaceutical Co. Ltd.
www.shire.com

Latest From Shire Regenerative Medicine Inc.

Shedding Earlier Fears, Pharma Takes A Fresh Look At Cell, Gene Therapies

The early successes enjoyed by new autologous, cell-based cancer therapies, as well as new advances in gene therapy and regenerative medicine, have reignited interest at Big Pharma in these advanced treatments, said partnering executives at the recent Therapeutic Area Partnerships meeting in Boston.

BioPharmaceutical Deals

Organogenesis Prepares To Restructure In The Face Of New CMS Skin-Substitute Policy

The maker of Apligraf for foot ulcers and venous leg ulcers is facing a more than 30% reduction in Medicare reimbursement starting Jan. 1. Organogenesis’ CEO says the firm is readying a plan to significantly trim its business costs so it can continue to market the PMA-approved, bioengineered product.

Medical Device

Organogenesis Prepares To Restructure In The Face Of New CMS Skin-Substitute Policy

The maker of Apligraf for foot ulcers and venous leg ulcers is facing a more than 30 percent reduction in Medicare reimbursement starting Jan. 1. Organogenesis’ CEO says the firm is readying a plan to significantly trim its business costs so it can continue to market the PMA-approved, bioengineered product.

Medical Device Reimbursement

Advanced Wound Care: A Future Built On Innovation

The advanced wound care market is attracting an increasing number of competitors and investors seeking a stake in this high-need, high-growth space. But although the number of innovative wound care products is on the rise, this is also a highly diverse market, with some striking differences among various regions of the world in terms of product adoption and standard wound care practices.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
    • Biomaterials
  • Therapeutic Areas
  • Dermatology
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Advanced BioHealing Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Jeff Jonas, MD, Pres.
  • Contact Info
  • Shire Regenerative Medicine Inc.
    11095 Torreyana Rd.
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register